

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.64028879 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.64028879 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.40063289 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.40063289 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.84241526 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.31252805 |
| 7 | cysteine metabolic process (GO:0006534) | 4.21829306 |
| 8 | bile acid biosynthetic process (GO:0006699) | 4.15974516 |
| 9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.11407921 |
| 10 | protein carboxylation (GO:0018214) | 4.11407921 |
| 11 | proteasome assembly (GO:0043248) | 4.08343855 |
| 12 | tryptophan catabolic process (GO:0006569) | 4.04033047 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 4.04033047 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 4.04033047 |
| 15 | aldehyde catabolic process (GO:0046185) | 4.00989494 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 3.92770192 |
| 17 | glyoxylate metabolic process (GO:0046487) | 3.89724849 |
| 18 | tryptophan metabolic process (GO:0006568) | 3.86552400 |
| 19 | low-density lipoprotein particle remodeling (GO:0034374) | 3.78220648 |
| 20 | regulation of cholesterol esterification (GO:0010872) | 3.76440778 |
| 21 | response to peptidoglycan (GO:0032494) | 3.69856999 |
| 22 | kynurenine metabolic process (GO:0070189) | 3.63467022 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 3.62016879 |
| 24 | cofactor catabolic process (GO:0051187) | 3.60702569 |
| 25 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.60237135 |
| 26 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.60237135 |
| 27 | blood coagulation, intrinsic pathway (GO:0007597) | 3.58011202 |
| 28 | aromatic amino acid family metabolic process (GO:0009072) | 3.58004664 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.57176003 |
| 30 | bile acid metabolic process (GO:0008206) | 3.52744336 |
| 31 | complement activation, alternative pathway (GO:0006957) | 3.52640387 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 3.52430513 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.47612739 |
| 34 | regulation of protein activation cascade (GO:2000257) | 3.47445105 |
| 35 | high-density lipoprotein particle remodeling (GO:0034375) | 3.46239659 |
| 36 | regulation of fibrinolysis (GO:0051917) | 3.42428187 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 3.41282395 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 3.41282395 |
| 39 | macromolecular complex remodeling (GO:0034367) | 3.41282395 |
| 40 | urea metabolic process (GO:0019627) | 3.40168659 |
| 41 | urea cycle (GO:0000050) | 3.40168659 |
| 42 | negative regulation of fibrinolysis (GO:0051918) | 3.38156008 |
| 43 | positive regulation by symbiont of host defense response (GO:0052509) | 3.37579132 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 3.37579132 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.37579132 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.37579132 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.37579132 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 3.37579132 |
| 49 | serine family amino acid catabolic process (GO:0009071) | 3.36867604 |
| 50 | coenzyme catabolic process (GO:0009109) | 3.36645531 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 3.35341934 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 3.33592756 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.32658881 |
| 54 | regulation of complement activation (GO:0030449) | 3.29287604 |
| 55 | tyrosine metabolic process (GO:0006570) | 3.26383824 |
| 56 | ethanol oxidation (GO:0006069) | 3.24440464 |
| 57 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.24365564 |
| 58 | serine family amino acid biosynthetic process (GO:0009070) | 3.23521617 |
| 59 | respiratory burst (GO:0045730) | 3.23025290 |
| 60 | B cell mediated immunity (GO:0019724) | 3.22784254 |
| 61 | positive regulation of mast cell degranulation (GO:0043306) | 3.21259816 |
| 62 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.21259816 |
| 63 | microglial cell activation (GO:0001774) | 3.20671627 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 3.19418407 |
| 65 | opsonization (GO:0008228) | 3.18125997 |
| 66 | macrophage activation involved in immune response (GO:0002281) | 3.17437733 |
| 67 | detection of molecule of bacterial origin (GO:0032490) | 3.16998218 |
| 68 | glycine metabolic process (GO:0006544) | 3.14407763 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 3.12603547 |
| 70 | negative regulation of interleukin-12 production (GO:0032695) | 3.12420187 |
| 71 | phospholipid efflux (GO:0033700) | 3.11907793 |
| 72 | imidazole-containing compound metabolic process (GO:0052803) | 3.11086074 |
| 73 | alpha-amino acid catabolic process (GO:1901606) | 3.08646882 |
| 74 | positive regulation of mast cell activation (GO:0033005) | 3.06506808 |
| 75 | fibrinolysis (GO:0042730) | 3.04283399 |
| 76 | amino-acid betaine metabolic process (GO:0006577) | 3.04002904 |
| 77 | cellular biogenic amine catabolic process (GO:0042402) | 3.01779685 |
| 78 | amine catabolic process (GO:0009310) | 3.01779685 |
| 79 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.00820249 |
| 80 | primary alcohol catabolic process (GO:0034310) | 3.00535720 |
| 81 | disruption of cells of other organism (GO:0044364) | 2.99762886 |
| 82 | killing of cells of other organism (GO:0031640) | 2.99762886 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.99107733 |
| 84 | neutrophil mediated immunity (GO:0002446) | 2.98125240 |
| 85 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.96517877 |
| 86 | homocysteine metabolic process (GO:0050667) | 2.96391014 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 2.96041467 |
| 88 | ethanol metabolic process (GO:0006067) | 2.88632883 |
| 89 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.87904235 |
| 90 | triglyceride homeostasis (GO:0070328) | 2.86564836 |
| 91 | acylglycerol homeostasis (GO:0055090) | 2.86564836 |
| 92 | protein activation cascade (GO:0072376) | 2.86063876 |
| 93 | indolalkylamine metabolic process (GO:0006586) | 2.85561047 |
| 94 | reverse cholesterol transport (GO:0043691) | 2.85539175 |
| 95 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85359133 |
| 96 | neutrophil activation (GO:0042119) | 2.84428071 |
| 97 | bile acid and bile salt transport (GO:0015721) | 2.84366934 |
| 98 | L-serine metabolic process (GO:0006563) | 2.84240429 |
| 99 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84110811 |
| 100 | cholesterol efflux (GO:0033344) | 2.83704226 |
| 101 | DNA deamination (GO:0045006) | 2.82923180 |
| 102 | S-adenosylmethionine metabolic process (GO:0046500) | 2.81212092 |
| 103 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.80650534 |
| 104 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.80384084 |
| 105 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.80376083 |
| 106 | response to interferon-beta (GO:0035456) | 2.79600163 |
| 107 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.79086569 |
| 108 | urate metabolic process (GO:0046415) | 2.78565657 |
| 109 | very long-chain fatty acid metabolic process (GO:0000038) | 2.78195194 |
| 110 | cellular amino acid catabolic process (GO:0009063) | 2.77988003 |
| 111 | mast cell activation (GO:0045576) | 2.77416580 |
| 112 | NAD biosynthetic process (GO:0009435) | 2.76726298 |
| 113 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.75493088 |
| 114 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.75493088 |
| 115 | signal peptide processing (GO:0006465) | 2.74960063 |
| 116 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.73870364 |
| 117 | cellular glucuronidation (GO:0052695) | 2.73257306 |
| 118 | cell wall macromolecule catabolic process (GO:0016998) | 2.72613235 |
| 119 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.72096832 |
| 120 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.70646710 |
| 121 | macrophage activation (GO:0042116) | 2.70530565 |
| 122 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.69433465 |
| 123 | complement activation (GO:0006956) | 2.69372107 |
| 124 | positive regulation of interferon-alpha production (GO:0032727) | 2.68794473 |
| 125 | cellular ketone body metabolic process (GO:0046950) | 2.68702966 |
| 126 | regulation of RIG-I signaling pathway (GO:0039535) | 2.68586591 |
| 127 | benzene-containing compound metabolic process (GO:0042537) | 2.68365053 |
| 128 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.68225470 |
| 129 | negative regulation of ligase activity (GO:0051352) | 2.68225470 |
| 130 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.68211979 |
| 131 | regulation of cholesterol metabolic process (GO:0090181) | 2.67842253 |
| 132 | acute-phase response (GO:0006953) | 2.67497002 |
| 133 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.67342760 |
| 134 | short-chain fatty acid metabolic process (GO:0046459) | 2.66679862 |
| 135 | response to nitrosative stress (GO:0051409) | 2.66277205 |
| 136 | ribosome assembly (GO:0042255) | 2.65250393 |
| 137 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.64989432 |
| 138 | granulocyte activation (GO:0036230) | 2.64856222 |
| 139 | complement activation, classical pathway (GO:0006958) | 2.64454992 |
| 140 | regulation of interferon-alpha production (GO:0032647) | 2.64445772 |
| 141 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.63276514 |
| 142 | negative regulation of growth of symbiont in host (GO:0044130) | 2.62197854 |
| 143 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.62197854 |
| 144 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.62197854 |
| 145 | regulation of growth of symbiont in host (GO:0044126) | 2.62197854 |
| 146 | negative regulation of sterol transport (GO:0032372) | 2.62081626 |
| 147 | negative regulation of cholesterol transport (GO:0032375) | 2.62081626 |
| 148 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.62060995 |
| 149 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.61803668 |
| 150 | plasma lipoprotein particle organization (GO:0071827) | 2.61480754 |
| 151 | glucuronate metabolic process (GO:0019585) | 2.61426202 |
| 152 | uronic acid metabolic process (GO:0006063) | 2.61426202 |
| 153 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.61031683 |
| 154 | positive regulation of type 2 immune response (GO:0002830) | 2.60295246 |
| 155 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.60046287 |
| 156 | organic acid catabolic process (GO:0016054) | 2.59510264 |
| 157 | carboxylic acid catabolic process (GO:0046395) | 2.59510264 |
| 158 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58924405 |
| 159 | ribosomal large subunit biogenesis (GO:0042273) | 2.58907111 |
| 160 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.58475575 |
| 161 | regulation of mast cell degranulation (GO:0043304) | 2.57293017 |
| 162 | detection of external biotic stimulus (GO:0098581) | 2.56769646 |
| 163 | regulation of mast cell activation (GO:0033003) | 2.55781856 |
| 164 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.55226852 |
| 165 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.55226852 |
| 166 | cellular response to interferon-beta (GO:0035458) | 2.54902301 |
| 167 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.53532429 |
| 168 | response to host immune response (GO:0052572) | 2.53532429 |
| 169 | positive regulation of B cell differentiation (GO:0045579) | 2.53345308 |
| 170 | chaperone-mediated protein transport (GO:0072321) | 2.52879014 |
| 171 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.52138060 |
| 172 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.51909068 |
| 173 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.51909068 |
| 174 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.51909068 |
| 175 | regulation of hypersensitivity (GO:0002883) | 2.49499842 |
| 176 | detection of other organism (GO:0098543) | 2.47251882 |
| 177 | response to xenobiotic stimulus (GO:0009410) | 2.45297246 |
| 178 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.44609096 |
| 179 | deoxyribose phosphate catabolic process (GO:0046386) | 2.43874410 |
| 180 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.42736940 |
| 181 | defense response to protozoan (GO:0042832) | 2.41943931 |
| 182 | termination of RNA polymerase III transcription (GO:0006386) | 2.41746898 |
| 183 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.41746898 |
| 184 | positive regulation of ligase activity (GO:0051351) | 2.41726276 |
| 185 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.41420282 |
| 186 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.41420282 |
| 187 | positive regulation of interleukin-17 production (GO:0032740) | 2.38062767 |
| 188 | myeloid leukocyte mediated immunity (GO:0002444) | 2.37445919 |
| 189 | positive regulation of interferon-beta production (GO:0032728) | 2.36727086 |
| 190 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.36433420 |
| 191 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.34882164 |
| 192 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.34790253 |
| 193 | ATP synthesis coupled proton transport (GO:0015986) | 2.34252038 |
| 194 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.34252038 |
| 195 | leukocyte degranulation (GO:0043299) | 2.33973956 |
| 196 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.33190046 |
| 197 | cellular response to interferon-gamma (GO:0071346) | 2.33030922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.32423397 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.98156815 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.60145115 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.21737823 |
| 5 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.87198011 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.55444577 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.54819918 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.38291075 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.18680040 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.11321928 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.96949684 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.84368771 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.67624017 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.30150603 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.24139453 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.19663289 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.18973277 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.18728525 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16137495 |
| 20 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.12427123 |
| 21 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.08326551 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06888607 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05123912 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.00435090 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.95364053 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92715700 |
| 27 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.92210589 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87933992 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.83010712 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.80601345 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.79609003 |
| 32 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.78747114 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77982810 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77753809 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77349734 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.75746683 |
| 37 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.74968495 |
| 38 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69332240 |
| 39 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.67514692 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.65958555 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65035465 |
| 42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.64701006 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.59696647 |
| 44 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.58471265 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58144480 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55609195 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55230203 |
| 48 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.54670049 |
| 49 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.51598161 |
| 50 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.48417891 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46374642 |
| 52 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.45359984 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42627719 |
| 54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39242680 |
| 55 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38380941 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35611271 |
| 57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33672525 |
| 58 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.33424858 |
| 59 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32668236 |
| 60 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32478072 |
| 61 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.29454339 |
| 62 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28729115 |
| 63 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.28222391 |
| 64 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.26149106 |
| 65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.22028629 |
| 66 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.21714450 |
| 67 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.21120124 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20124413 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19694718 |
| 70 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.19459777 |
| 71 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.19186969 |
| 72 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.18642354 |
| 73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.17108863 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16527566 |
| 75 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.16480940 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.16311336 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12987783 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11324126 |
| 79 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.11232377 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08608030 |
| 81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07224845 |
| 82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06920540 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06536140 |
| 84 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06132881 |
| 85 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05951296 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05264009 |
| 87 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.05099241 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04452270 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03409073 |
| 90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03077451 |
| 91 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.01368050 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01276216 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01161583 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99578339 |
| 95 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.99456729 |
| 96 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.98933469 |
| 97 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98745449 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98568746 |
| 99 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.98296589 |
| 100 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.98270969 |
| 101 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98121690 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97399757 |
| 103 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96029789 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95532142 |
| 105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95386423 |
| 106 | MYB_26560356_Chip-Seq_TH2_Human | 0.94483150 |
| 107 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.94329130 |
| 108 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.93586792 |
| 109 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.93565134 |
| 110 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.93302247 |
| 111 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92889748 |
| 112 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.92647056 |
| 113 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92425011 |
| 114 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.92393400 |
| 115 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.92237772 |
| 116 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.90266737 |
| 117 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.90068012 |
| 118 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88686446 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88505857 |
| 120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88442928 |
| 121 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.87920624 |
| 122 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87321398 |
| 123 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.86614813 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85748258 |
| 125 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85107504 |
| 126 | MYB_26560356_Chip-Seq_TH1_Human | 0.84242003 |
| 127 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83463532 |
| 128 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.82007532 |
| 129 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81784938 |
| 130 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.81721707 |
| 131 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.80693017 |
| 132 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.79548983 |
| 133 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77711269 |
| 134 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77407815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.43928652 |
| 2 | MP0005360_urolithiasis | 4.72997823 |
| 3 | MP0005365_abnormal_bile_salt | 4.03791846 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.93689589 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.60744865 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.49473394 |
| 7 | MP0009840_abnormal_foam_cell | 3.06665045 |
| 8 | MP0003724_increased_susceptibility_to | 2.63951706 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.58797868 |
| 10 | MP0003436_decreased_susceptibility_to | 2.46005757 |
| 11 | MP0003252_abnormal_bile_duct | 2.40330737 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.30544867 |
| 13 | MP0003195_calcinosis | 2.27167292 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.20001506 |
| 15 | MP0005332_abnormal_amino_acid | 2.16389118 |
| 16 | MP0005083_abnormal_biliary_tract | 2.13159270 |
| 17 | MP0003186_abnormal_redox_activity | 2.08193033 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.01780437 |
| 19 | MP0001666_abnormal_nutrient_absorption | 1.95848297 |
| 20 | MP0003656_abnormal_erythrocyte_physiolo | 1.93930397 |
| 21 | MP0009785_altered_susceptibility_to | 1.91550830 |
| 22 | MP0002419_abnormal_innate_immunity | 1.83574756 |
| 23 | MP0001853_heart_inflammation | 1.83209365 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.78773183 |
| 25 | MP0008058_abnormal_DNA_repair | 1.78093659 |
| 26 | MP0005025_abnormal_response_to | 1.75953623 |
| 27 | MP0009764_decreased_sensitivity_to | 1.71421758 |
| 28 | MP0005451_abnormal_body_composition | 1.71418912 |
| 29 | MP0000609_abnormal_liver_physiology | 1.69020356 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.67300859 |
| 31 | MP0000685_abnormal_immune_system | 1.65576049 |
| 32 | MP0008469_abnormal_protein_level | 1.61878460 |
| 33 | MP0003303_peritoneal_inflammation | 1.61616020 |
| 34 | MP0006082_CNS_inflammation | 1.60454364 |
| 35 | MP0001764_abnormal_homeostasis | 1.56948673 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.56829328 |
| 37 | MP0005671_abnormal_response_to | 1.55523317 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 1.54298523 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.52657665 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.52082117 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.50013685 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49056179 |
| 43 | MP0010094_abnormal_chromosome_stability | 1.45991586 |
| 44 | MP0003011_delayed_dark_adaptation | 1.45541302 |
| 45 | MP0005310_abnormal_salivary_gland | 1.44948605 |
| 46 | MP0009697_abnormal_copulation | 1.44144743 |
| 47 | MP0000604_amyloidosis | 1.43090331 |
| 48 | MP0004957_abnormal_blastocyst_morpholog | 1.38374613 |
| 49 | MP0004019_abnormal_vitamin_homeostasis | 1.37722103 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.35815836 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.35382600 |
| 52 | MP0002723_abnormal_immune_serum | 1.34631998 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.33701206 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.33701206 |
| 55 | MP0003868_abnormal_feces_composition | 1.30685614 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.29589537 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.29449113 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.29165018 |
| 59 | MP0001800_abnormal_humoral_immune | 1.28759216 |
| 60 | MP0009379_abnormal_foot_pigmentation | 1.26416016 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.25175916 |
| 62 | MP0006035_abnormal_mitochondrial_morpho | 1.23236544 |
| 63 | MP0001790_abnormal_immune_system | 1.20934577 |
| 64 | MP0005387_immune_system_phenotype | 1.20934577 |
| 65 | MP0005410_abnormal_fertilization | 1.18860728 |
| 66 | MP0009763_increased_sensitivity_to | 1.17686177 |
| 67 | MP0004381_abnormal_hair_follicle | 1.17322776 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.16749786 |
| 69 | MP0003718_maternal_effect | 1.15864285 |
| 70 | MP0003075_altered_response_to | 1.12960338 |
| 71 | MP0005636_abnormal_mineral_homeostasis | 1.12851720 |
| 72 | MP0002420_abnormal_adaptive_immunity | 1.12837572 |
| 73 | MP0001819_abnormal_immune_cell | 1.12380056 |
| 74 | MP0003077_abnormal_cell_cycle | 1.11611363 |
| 75 | MP0009643_abnormal_urine_homeostasis | 1.10499707 |
| 76 | MP0003693_abnormal_embryo_hatching | 1.10355547 |
| 77 | MP0005174_abnormal_tail_pigmentation | 1.09143661 |
| 78 | MP0002166_altered_tumor_susceptibility | 1.07891096 |
| 79 | MP0002396_abnormal_hematopoietic_system | 1.05796405 |
| 80 | MP0000920_abnormal_myelination | 1.04673401 |
| 81 | MP0000703_abnormal_thymus_morphology | 1.04287647 |
| 82 | MP0003866_abnormal_defecation | 1.02593310 |
| 83 | MP0003690_abnormal_glial_cell | 1.01588402 |
| 84 | MP0008057_abnormal_DNA_replication | 1.00538241 |
| 85 | MP0003300_gastrointestinal_ulcer | 0.99574561 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 0.98882057 |
| 87 | MP0000358_abnormal_cell_content/ | 0.97032197 |
| 88 | MP0003786_premature_aging | 0.96950913 |
| 89 | MP0003448_altered_tumor_morphology | 0.95006299 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 0.93746176 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.92436064 |
| 92 | MP0001727_abnormal_embryo_implantation | 0.91657475 |
| 93 | MP0003329_amyloid_beta_deposits | 0.91378142 |
| 94 | MP0002405_respiratory_system_inflammati | 0.90503500 |
| 95 | MP0004947_skin_inflammation | 0.88424477 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.87728369 |
| 97 | MP0000598_abnormal_liver_morphology | 0.86818786 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.86100774 |
| 99 | MP0008877_abnormal_DNA_methylation | 0.85828609 |
| 100 | MP0002254_reproductive_system_inflammat | 0.85680564 |
| 101 | MP0005220_abnormal_exocrine_pancreas | 0.85419886 |
| 102 | MP0000716_abnormal_immune_system | 0.85019702 |
| 103 | MP0000313_abnormal_cell_death | 0.83997729 |
| 104 | MP0005164_abnormal_response_to | 0.83654768 |
| 105 | MP0005166_decreased_susceptibility_to | 0.82905185 |
| 106 | MP0009642_abnormal_blood_homeostasis | 0.81886798 |
| 107 | MP0002933_joint_inflammation | 0.81046634 |
| 108 | MP0005408_hypopigmentation | 0.81014678 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.80986435 |
| 110 | MP0000343_altered_response_to | 0.80343331 |
| 111 | MP0010155_abnormal_intestine_physiology | 0.79414121 |
| 112 | MP0002006_tumorigenesis | 0.79144962 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78380255 |
| 114 | MP0001851_eye_inflammation | 0.77093157 |
| 115 | MP0003111_abnormal_nucleus_morphology | 0.76294399 |
| 116 | MP0000689_abnormal_spleen_morphology | 0.74818403 |
| 117 | MP0001542_abnormal_bone_strength | 0.74466289 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.73155771 |
| 119 | MP0002095_abnormal_skin_pigmentation | 0.71299678 |
| 120 | MP0000858_altered_metastatic_potential | 0.70952726 |
| 121 | MP0008260_abnormal_autophagy | 0.70756783 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.70505933 |
| 123 | MP0008007_abnormal_cellular_replicative | 0.70465445 |
| 124 | MP0005647_abnormal_sex_gland | 0.69956666 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.69942592 |
| 126 | MP0002398_abnormal_bone_marrow | 0.69494064 |
| 127 | MP0000490_abnormal_crypts_of | 0.68685570 |
| 128 | MP0001661_extended_life_span | 0.68552707 |
| 129 | MP0004147_increased_porphyrin_level | 0.68275901 |
| 130 | MP0002429_abnormal_blood_cell | 0.68167457 |
| 131 | MP0003183_abnormal_peptide_metabolism | 0.66085317 |
| 132 | MP0005266_abnormal_metabolism | 0.65650014 |
| 133 | MP0003646_muscle_fatigue | 0.65572383 |
| 134 | MP0001929_abnormal_gametogenesis | 0.65220638 |
| 135 | MP0003828_pulmonary_edema | 0.65127980 |
| 136 | MP0002132_abnormal_respiratory_system | 0.64529787 |
| 137 | MP0003763_abnormal_thymus_physiology | 0.63755459 |
| 138 | MP0005535_abnormal_body_temperature | 0.63248252 |
| 139 | MP0002136_abnormal_kidney_physiology | 0.63060333 |
| 140 | MP0008873_increased_physiological_sensi | 0.62734858 |
| 141 | MP0002722_abnormal_immune_system | 0.61922920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.95348995 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 5.00474488 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.37879839 |
| 4 | Xanthomatosis (HP:0000991) | 4.27120230 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.14242375 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.12969440 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 4.10653990 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.10383176 |
| 9 | Deep venous thrombosis (HP:0002625) | 4.09401861 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.69342113 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.65144539 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.65144539 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.62363715 |
| 14 | Obstructive lung disease (HP:0006536) | 3.62363715 |
| 15 | Joint hemorrhage (HP:0005261) | 3.58143220 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.40523025 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.31739195 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.27534273 |
| 19 | Complement deficiency (HP:0004431) | 3.20151479 |
| 20 | Myositis (HP:0100614) | 3.17305470 |
| 21 | Fat malabsorption (HP:0002630) | 3.14412598 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.11297159 |
| 23 | Acute necrotizing encephalopathy (HP:0006965) | 3.05304706 |
| 24 | Reduced antithrombin III activity (HP:0001976) | 3.01372921 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.00742355 |
| 26 | Optic neuritis (HP:0100653) | 3.00742355 |
| 27 | Hyperammonemia (HP:0001987) | 3.00252953 |
| 28 | Hyperglycinemia (HP:0002154) | 2.95197100 |
| 29 | Aplastic anemia (HP:0001915) | 2.92595490 |
| 30 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.90667013 |
| 31 | Orchitis (HP:0100796) | 2.87277603 |
| 32 | Steatorrhea (HP:0002570) | 2.86573756 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 2.86005234 |
| 34 | Hypoglycemic coma (HP:0001325) | 2.82184250 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.82083094 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.79571182 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 2.79571182 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.78440436 |
| 39 | Hemoptysis (HP:0002105) | 2.76967730 |
| 40 | Mitochondrial inheritance (HP:0001427) | 2.75400296 |
| 41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.74511614 |
| 42 | Increased CSF lactate (HP:0002490) | 2.74113811 |
| 43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.74006824 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.70790422 |
| 45 | Hypolipoproteinemia (HP:0010981) | 2.70409067 |
| 46 | Ketosis (HP:0001946) | 2.68785552 |
| 47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.66532617 |
| 48 | Type I transferrin isoform profile (HP:0003642) | 2.66382885 |
| 49 | Hyperglycinuria (HP:0003108) | 2.63266869 |
| 50 | Meningitis (HP:0001287) | 2.62982730 |
| 51 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.62844037 |
| 52 | Anorexia (HP:0002039) | 2.61759853 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.60562244 |
| 54 | Abnormality of complement system (HP:0005339) | 2.60468565 |
| 55 | Recurrent skin infections (HP:0001581) | 2.60306280 |
| 56 | Epidermoid cyst (HP:0200040) | 2.56855379 |
| 57 | Encephalitis (HP:0002383) | 2.55960979 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.55648377 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.55183029 |
| 60 | Progressive macrocephaly (HP:0004481) | 2.55169233 |
| 61 | Abnormality of serum amino acid levels (HP:0003112) | 2.49251290 |
| 62 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.48864718 |
| 63 | Glomerulonephritis (HP:0000099) | 2.48709246 |
| 64 | Vasculitis (HP:0002633) | 2.48442285 |
| 65 | Myocardial infarction (HP:0001658) | 2.46648678 |
| 66 | Agnosia (HP:0010524) | 2.45829674 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.43828928 |
| 68 | Hyperbilirubinemia (HP:0002904) | 2.43200619 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.41306827 |
| 70 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40696011 |
| 71 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40696011 |
| 72 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40696011 |
| 73 | Cerebral edema (HP:0002181) | 2.40167242 |
| 74 | Axonal loss (HP:0003447) | 2.37838775 |
| 75 | Keratoconjunctivitis (HP:0001096) | 2.37364332 |
| 76 | Conjugated hyperbilirubinemia (HP:0002908) | 2.37227535 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.36967534 |
| 78 | Purpura (HP:0000979) | 2.36136762 |
| 79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.35260674 |
| 80 | Dicarboxylic aciduria (HP:0003215) | 2.35260674 |
| 81 | Polyneuropathy (HP:0001271) | 2.35195709 |
| 82 | Recurrent viral infections (HP:0004429) | 2.35114899 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.33940279 |
| 84 | Gangrene (HP:0100758) | 2.31209954 |
| 85 | Increased serum ferritin (HP:0003281) | 2.28186087 |
| 86 | Hepatic necrosis (HP:0002605) | 2.28098213 |
| 87 | Amyloidosis (HP:0011034) | 2.27865903 |
| 88 | Abnormality of iron homeostasis (HP:0011031) | 2.27488257 |
| 89 | Upper motor neuron abnormality (HP:0002127) | 2.26912395 |
| 90 | Skin rash (HP:0000988) | 2.26857065 |
| 91 | Panhypogammaglobulinemia (HP:0003139) | 2.26359226 |
| 92 | Microvesicular hepatic steatosis (HP:0001414) | 2.25446342 |
| 93 | Exertional dyspnea (HP:0002875) | 2.24538419 |
| 94 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.23093749 |
| 95 | Pulmonary infiltrates (HP:0002113) | 2.22273404 |
| 96 | Lethargy (HP:0001254) | 2.22264248 |
| 97 | Gingival bleeding (HP:0000225) | 2.21891031 |
| 98 | Increased IgM level (HP:0003496) | 2.20780549 |
| 99 | Delayed CNS myelination (HP:0002188) | 2.19209872 |
| 100 | T lymphocytopenia (HP:0005403) | 2.18140811 |
| 101 | Hypercholesterolemia (HP:0003124) | 2.17653955 |
| 102 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.15995330 |
| 103 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.15995330 |
| 104 | Abnormal protein glycosylation (HP:0012346) | 2.15995330 |
| 105 | Abnormal glycosylation (HP:0012345) | 2.15995330 |
| 106 | Keratoconjunctivitis sicca (HP:0001097) | 2.15661190 |
| 107 | Chronic otitis media (HP:0000389) | 2.15380555 |
| 108 | IgG deficiency (HP:0004315) | 2.15032874 |
| 109 | Multiple enchondromatosis (HP:0005701) | 2.14897778 |
| 110 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11452816 |
| 111 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.10419578 |
| 112 | Granulocytopenia (HP:0001913) | 2.08218139 |
| 113 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.07977748 |
| 114 | Menorrhagia (HP:0000132) | 2.07099221 |
| 115 | Abnormality of T cells (HP:0002843) | 2.06967892 |
| 116 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.06894534 |
| 117 | Epistaxis (HP:0000421) | 2.05890230 |
| 118 | Acanthocytosis (HP:0001927) | 2.05536767 |
| 119 | Fatigue (HP:0012378) | 2.05535006 |
| 120 | Spastic paraparesis (HP:0002313) | 2.03667539 |
| 121 | Increased intramyocellular lipid droplets (HP:0012240) | 2.01430416 |
| 122 | Leukocytosis (HP:0001974) | 2.01351408 |
| 123 | Abnormal spermatogenesis (HP:0008669) | 2.00510459 |
| 124 | Hypoalphalipoproteinemia (HP:0003233) | 2.00237899 |
| 125 | Chest pain (HP:0100749) | 1.99989509 |
| 126 | Oral leukoplakia (HP:0002745) | 1.99694327 |
| 127 | Renal Fanconi syndrome (HP:0001994) | 1.98858749 |
| 128 | Abnormality of T cell number (HP:0011839) | 1.98063198 |
| 129 | Increased muscle lipid content (HP:0009058) | 1.98005829 |
| 130 | Amaurosis fugax (HP:0100576) | 1.97942927 |
| 131 | Cerebral hemorrhage (HP:0001342) | 1.97653658 |
| 132 | Basal ganglia calcification (HP:0002135) | 1.97344358 |
| 133 | Abnormality of nucleobase metabolism (HP:0010932) | 1.97288846 |
| 134 | Lactic acidosis (HP:0003128) | 1.97152158 |
| 135 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.96949290 |
| 136 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.96949290 |
| 137 | Hepatocellular necrosis (HP:0001404) | 1.96748347 |
| 138 | Increased serum lactate (HP:0002151) | 1.96441771 |
| 139 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.95972047 |
| 140 | Abnormality of T cell physiology (HP:0011840) | 1.95662688 |
| 141 | Ketoacidosis (HP:0001993) | 1.94802647 |
| 142 | Hepatosplenomegaly (HP:0001433) | 1.94087865 |
| 143 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93993229 |
| 144 | Glomerulopathy (HP:0100820) | 1.93265788 |
| 145 | Irritability (HP:0000737) | 1.93141343 |
| 146 | Metabolic acidosis (HP:0001942) | 1.93026071 |
| 147 | Abnormality of purine metabolism (HP:0004352) | 1.92486002 |
| 148 | 3-Methylglutaconic aciduria (HP:0003535) | 1.92352019 |
| 149 | Pancreatitis (HP:0001733) | 1.92027659 |
| 150 | Disinhibition (HP:0000734) | 1.91766846 |
| 151 | Stomatitis (HP:0010280) | 1.91423168 |
| 152 | Glycosuria (HP:0003076) | 1.90948980 |
| 153 | Abnormality of urine glucose concentration (HP:0011016) | 1.90948980 |
| 154 | Eosinophilia (HP:0001880) | 1.90730567 |
| 155 | Lipid accumulation in hepatocytes (HP:0006561) | 1.90536544 |
| 156 | Urticaria (HP:0001025) | 1.90374292 |
| 157 | Abnormality of the pleura (HP:0002103) | 1.90171164 |
| 158 | Acute encephalopathy (HP:0006846) | 1.88876627 |
| 159 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.88207018 |
| 160 | Nausea (HP:0002018) | 1.88105052 |
| 161 | Vascular calcification (HP:0004934) | 1.87729414 |
| 162 | Tinnitus (HP:0000360) | 1.85478161 |
| 163 | Pulmonary fibrosis (HP:0002206) | 1.85374347 |
| 164 | Acute hepatic failure (HP:0006554) | 1.85138543 |
| 165 | Opisthotonus (HP:0002179) | 1.84403978 |
| 166 | Brushfield spots (HP:0001088) | 1.84307360 |
| 167 | Pulmonary embolism (HP:0002204) | 1.84005542 |
| 168 | Increased hepatocellular lipid droplets (HP:0006565) | 1.82151034 |
| 169 | Paraparesis (HP:0002385) | 1.81438717 |
| 170 | Degeneration of anterior horn cells (HP:0002398) | 1.81417212 |
| 171 | Abnormality of the anterior horn cell (HP:0006802) | 1.81417212 |
| 172 | Spontaneous abortion (HP:0005268) | 1.80491989 |
| 173 | Petechiae (HP:0000967) | 1.80204340 |
| 174 | Microcytic anemia (HP:0001935) | 1.80011170 |
| 175 | Neurofibrillary tangles (HP:0002185) | 1.79771047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.45687256 |
| 2 | BCKDK | 2.80263265 |
| 3 | PIM2 | 2.79038867 |
| 4 | EIF2AK3 | 2.61519359 |
| 5 | BLK | 2.59383964 |
| 6 | EIF2AK1 | 2.41360827 |
| 7 | IRAK4 | 2.37883775 |
| 8 | RIPK4 | 2.37651440 |
| 9 | TYK2 | 2.30435651 |
| 10 | STK16 | 2.17551607 |
| 11 | TEC | 2.16803050 |
| 12 | PBK | 2.16493655 |
| 13 | TBK1 | 2.16102329 |
| 14 | ERN1 | 2.08179579 |
| 15 | ACVR1B | 2.07690475 |
| 16 | TAOK3 | 2.04043383 |
| 17 | IRAK3 | 1.89975386 |
| 18 | KDR | 1.83552837 |
| 19 | ABL2 | 1.83263928 |
| 20 | NEK1 | 1.82780587 |
| 21 | TESK2 | 1.81918070 |
| 22 | KIT | 1.79813267 |
| 23 | ARAF | 1.78432022 |
| 24 | MAP3K14 | 1.76325201 |
| 25 | MAP4K1 | 1.58668234 |
| 26 | BTK | 1.57841559 |
| 27 | VRK2 | 1.46051373 |
| 28 | NLK | 1.45045984 |
| 29 | PIK3CG | 1.41225405 |
| 30 | BUB1 | 1.39418754 |
| 31 | IKBKE | 1.35198972 |
| 32 | SRPK1 | 1.33752542 |
| 33 | NEK9 | 1.33253209 |
| 34 | FLT3 | 1.31399584 |
| 35 | RPS6KA4 | 1.30447362 |
| 36 | LRRK2 | 1.25163810 |
| 37 | TNIK | 1.23130172 |
| 38 | IRAK1 | 1.22153761 |
| 39 | FGFR4 | 1.21273805 |
| 40 | JAK3 | 1.20494024 |
| 41 | FES | 1.19741366 |
| 42 | PLK4 | 1.19224366 |
| 43 | IKBKB | 1.16404375 |
| 44 | PDK2 | 1.14735157 |
| 45 | IRAK2 | 1.14171339 |
| 46 | ZAP70 | 1.07462545 |
| 47 | TRIM28 | 1.07123655 |
| 48 | LYN | 1.05939590 |
| 49 | CSF1R | 1.03360300 |
| 50 | BMPR1B | 1.03225999 |
| 51 | MAPKAPK5 | 1.02287810 |
| 52 | MST4 | 0.98964034 |
| 53 | SCYL2 | 0.97965365 |
| 54 | SYK | 0.97656824 |
| 55 | ITK | 0.97206944 |
| 56 | MAPK15 | 0.96758109 |
| 57 | DYRK3 | 0.96458096 |
| 58 | FGR | 0.95832034 |
| 59 | MAP4K2 | 0.95480237 |
| 60 | EPHB1 | 0.93923924 |
| 61 | MAP3K1 | 0.89537393 |
| 62 | MATK | 0.88539562 |
| 63 | PAK4 | 0.87940954 |
| 64 | CSK | 0.87643228 |
| 65 | MARK3 | 0.86726984 |
| 66 | MST1R | 0.86257251 |
| 67 | MAPK4 | 0.84630976 |
| 68 | SIK1 | 0.83014356 |
| 69 | JAK2 | 0.82266694 |
| 70 | GRK6 | 0.81869934 |
| 71 | PLK2 | 0.81322128 |
| 72 | PIM1 | 0.81072412 |
| 73 | JAK1 | 0.80495669 |
| 74 | VRK1 | 0.79697306 |
| 75 | PRKCQ | 0.79237834 |
| 76 | MAPK11 | 0.79059348 |
| 77 | PTK2B | 0.77993400 |
| 78 | DAPK1 | 0.76977580 |
| 79 | RAF1 | 0.76968937 |
| 80 | STK39 | 0.76262921 |
| 81 | ERBB4 | 0.74728346 |
| 82 | GRK7 | 0.72525037 |
| 83 | MYLK | 0.72408851 |
| 84 | LCK | 0.72115190 |
| 85 | MAP3K12 | 0.71964153 |
| 86 | TESK1 | 0.71943963 |
| 87 | CDK19 | 0.70293977 |
| 88 | BRAF | 0.68668646 |
| 89 | MAP3K11 | 0.66413979 |
| 90 | TAOK2 | 0.65872717 |
| 91 | BMPR2 | 0.65190695 |
| 92 | TXK | 0.65136049 |
| 93 | ILK | 0.64417797 |
| 94 | PAK1 | 0.63686206 |
| 95 | MUSK | 0.59618819 |
| 96 | ABL1 | 0.58920400 |
| 97 | WEE1 | 0.58859395 |
| 98 | CDC7 | 0.58284167 |
| 99 | MAP2K3 | 0.58141431 |
| 100 | MAP3K3 | 0.57433131 |
| 101 | AURKB | 0.54602039 |
| 102 | HCK | 0.52905045 |
| 103 | PLK1 | 0.52719884 |
| 104 | ADRBK2 | 0.52035158 |
| 105 | CDK8 | 0.51783458 |
| 106 | RPS6KA5 | 0.51394326 |
| 107 | PRKG2 | 0.49768831 |
| 108 | CDK7 | 0.49215105 |
| 109 | STK4 | 0.49201612 |
| 110 | TNK2 | 0.48804705 |
| 111 | DYRK2 | 0.48485679 |
| 112 | TRPM7 | 0.47871146 |
| 113 | EIF2AK2 | 0.47584117 |
| 114 | PRKCD | 0.46911204 |
| 115 | CSNK2A2 | 0.46809377 |
| 116 | STK10 | 0.46355116 |
| 117 | CSNK2A1 | 0.44454761 |
| 118 | EGFR | 0.44046291 |
| 119 | MOS | 0.42685071 |
| 120 | CAMKK2 | 0.41931711 |
| 121 | FGFR2 | 0.41634110 |
| 122 | DYRK1B | 0.40915264 |
| 123 | PLK3 | 0.40902732 |
| 124 | MAP3K5 | 0.40479361 |
| 125 | MAPKAPK3 | 0.40474673 |
| 126 | CSNK1G1 | 0.39451346 |
| 127 | NUAK1 | 0.39325007 |
| 128 | FRK | 0.38618239 |
| 129 | OXSR1 | 0.38434061 |
| 130 | INSRR | 0.36834599 |
| 131 | MAP3K8 | 0.35737225 |
| 132 | BRSK2 | 0.35725742 |
| 133 | CSNK1G3 | 0.35083464 |
| 134 | MAPK12 | 0.34815614 |
| 135 | MAP3K13 | 0.34608756 |
| 136 | TGFBR2 | 0.34119282 |
| 137 | SIK3 | 0.33158781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.80350765 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.36157060 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.04760140 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.87679661 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.71736557 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.61573153 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.58505030 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48808843 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.45382216 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.40855357 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.36368418 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.35818320 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30502431 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23726870 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.15079138 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.14962367 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.04371033 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.00790085 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96955914 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.93945780 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92300611 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.91906249 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.87671312 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.86730726 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.86034478 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.82918723 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 1.81788188 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.81425053 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.80764904 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75804527 |
| 31 | Protein export_Homo sapiens_hsa03060 | 1.75458530 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.69161051 |
| 33 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.67835436 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.66655156 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.57475446 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53431905 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.51631678 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51382221 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50996347 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50947732 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.49352998 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.46662997 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.45485968 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 1.41943100 |
| 45 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.40372314 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39541671 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37915302 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.37682113 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34436461 |
| 50 | Proteasome_Homo sapiens_hsa03050 | 1.34069510 |
| 51 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.28509074 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.25987356 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.24562323 |
| 54 | Base excision repair_Homo sapiens_hsa03410 | 1.24433195 |
| 55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23848363 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.22059775 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.21928607 |
| 58 | Huntingtons disease_Homo sapiens_hsa05016 | 1.21490095 |
| 59 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.20549297 |
| 60 | Spliceosome_Homo sapiens_hsa03040 | 1.18041589 |
| 61 | RNA transport_Homo sapiens_hsa03013 | 1.11803056 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.11753157 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10582277 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10509709 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09546173 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08206783 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 1.05860226 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04085321 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03588205 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01219181 |
| 71 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00689893 |
| 72 | * Regulation of autophagy_Homo sapiens_hsa04140 | 1.00511645 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.98019273 |
| 74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97034788 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95654376 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.94333444 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90798044 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.88932929 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87334978 |
| 80 | RNA degradation_Homo sapiens_hsa03018 | 0.86049056 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84718596 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84624710 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82935160 |
| 84 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.82155830 |
| 85 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77552144 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75211884 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74995659 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74846940 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74620473 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72661038 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.72482017 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72035274 |
| 93 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71531065 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.70842831 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.70583394 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.69215997 |
| 97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.67707555 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.67565587 |
| 99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65130254 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.61633912 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.61172568 |
| 102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58196326 |
| 103 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58165035 |
| 104 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.57280628 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.56847301 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55910601 |
| 107 | RNA polymerase_Homo sapiens_hsa03020 | 0.54768396 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54740556 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54656298 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53898502 |
| 111 | Purine metabolism_Homo sapiens_hsa00230 | 0.52947392 |
| 112 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52919993 |
| 113 | Malaria_Homo sapiens_hsa05144 | 0.52778970 |
| 114 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50784736 |
| 115 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50449752 |
| 116 | Cell cycle_Homo sapiens_hsa04110 | 0.48414362 |
| 117 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47545663 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47484899 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45056330 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.44538626 |
| 121 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44257117 |
| 122 | Legionellosis_Homo sapiens_hsa05134 | 0.44196155 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41107448 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40984172 |
| 125 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.40333789 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.39299669 |
| 127 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.39287348 |
| 128 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.39174241 |
| 129 | Tuberculosis_Homo sapiens_hsa05152 | 0.38683918 |
| 130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.38079882 |
| 131 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.37562816 |
| 132 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37028311 |
| 133 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36245854 |
| 134 | Hepatitis B_Homo sapiens_hsa05161 | 0.35697135 |
| 135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35443503 |
| 136 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35411519 |
| 137 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34630796 |
| 138 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34194858 |
| 139 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33719851 |
| 140 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32902664 |
| 141 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.32679463 |
| 142 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31716860 |
| 143 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30969129 |
| 144 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.29392128 |
| 145 | Alzheimers disease_Homo sapiens_hsa05010 | 0.29229716 |
| 146 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.28811518 |
| 147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28423127 |
| 148 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.28319692 |
| 149 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.27871704 |
| 150 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27706437 |
| 151 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26879453 |
| 152 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26404429 |
| 153 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.24900746 |
| 154 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.23617666 |
| 155 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23452145 |
| 156 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22717451 |
| 157 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.22617504 |
| 158 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.22523326 |

